PureTech Health (PRTC) Return on Assets (2025)

PureTech Health (PRTC) reported Return on Assets of 0.0% for Q4 2025, down 6.24% on a QoQ basis from 0.0% in Q2 2025.

PureTech Health (PRTC) has 1 years of Return on Assets data on file, last reported at 0.0% in Q4 2025.

  • Quarterly Return on Assets changed N/A year-over-year to 0.0% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0% (changed N/A YoY) and the FY2025 annual result came in at 0.0%, changed N/A from the prior year.
  • Return on Assets slipped to 0.0% in Q4 2025 per PRTC's latest filing, from 0.0% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.0% in Q2 2025 and bottomed at 0.0% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - -0.01%
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn 0.00%
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - -0.01%
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn 0.00%
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn 0.00%
8 Evaxion A 65.44 Bn 65.42 Bn - 0.00%
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn 0.00%
10 PureTech Health 86.36 Mn -190.94 Mn - 0.00%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.00%
Jun 30, 2025 0.00%